User profiles for Dipesh C Patel
 | Dipesh C PatelUCL Verified email at doctors.org.uk Cited by 1405 |
[HTML][HTML] A narrative review of chronic kidney disease in clinical practice: current challenges and future perspectives
…, SC Bain, S Davies, U Dashora, Z Yousef, DC Patel… - Advances in …, 2022 - Springer
Chronic kidney disease (CKD) is a complex disease which affects approximately 13% of the
world’s population. Over time, CKD can cause renal dysfunction and progression to end-…
world’s population. Over time, CKD can cause renal dysfunction and progression to end-…
[HTML][HTML] Type 2 diabetes is associated with reduced ATP-binding cassette transporter A1 gene expression, protein and function
DC Patel, C Albrecht, D Pavitt, V Paul, C Pourreyron… - PloS one, 2011 - journals.plos.org
Objective Increasing plasma glucose levels are associated with increasing risk of vascular
disease. We tested the hypothesis that there is a glycaemia-mediated impairment of reverse …
disease. We tested the hypothesis that there is a glycaemia-mediated impairment of reverse …
[HTML][HTML] SGLT2 inhibitors: cardiovascular benefits beyond HbA1c—translating evidence into practice
Cardiovascular disease (CVD), including heart failure (HF), is a leading cause of morbidity
and mortality in people with type 2 diabetes mellitus (T2DM). CVD and T2DM share common …
and mortality in people with type 2 diabetes mellitus (T2DM). CVD and T2DM share common …
Systematic review of the barriers and facilitators to dietary modification in people living with type 2 diabetes and pre‐diabetes from South Asian ethnic populations
A Rai, R Misra, H Khan, S Shukla, DC Patel… - Diabetic …, 2023 - Wiley Online Library
Aims Lifestyle and dietary modification are effective in the prevention and management of
Type 2 diabetes Mellitus (T2DM). However, South Asian (SA) populations living in Western …
Type 2 diabetes Mellitus (T2DM). However, South Asian (SA) populations living in Western …
Clinical practice guidelines for management of hyperglycaemia in adults with diabetic kidney disease
A significant percentage of people with diabetes develop chronic kidney disease and diabetes
is also a leading cause of end‐stage kidney disease (ESKD). The term diabetic kidney …
is also a leading cause of end‐stage kidney disease (ESKD). The term diabetic kidney …
[HTML][HTML] A roadmap to recovery: ABCD recommendations on risk stratification of adult patients with diabetes in the post‐COVID‐19 era
…, P Winocour, G Ayman, R Patel, C Hambling… - Diabetic …, 2021 - ncbi.nlm.nih.gov
A third of the over 40,000 deaths in the United Kingdom attributed to the first wave of the
COVID-19 pandemic occurred in people with diabetes. 1 However, the focus on emergency …
COVID-19 pandemic occurred in people with diabetes. 1 However, the focus on emergency …
[HTML][HTML] Association of British Clinical Diabetologists (ABCD) and Diabetes UK joint position statement and recommendations for non-diabetes specialists on the use …
…, D Nagi, K Whitehead, H Beba, P De, DC Patel - Clinical …, 2021 - ncbi.nlm.nih.gov
Sodium glucose co-transporter 2 (SGLT2) inhibitors are now an established class of medications
for the treatment of type 2 diabetes (T2D), no longer reserved for use by specialists in …
for the treatment of type 2 diabetes (T2D), no longer reserved for use by specialists in …
New Therapeutic Horizons in Chronic Kidney Disease: The role of SGLT2 inhibitors in clinical practice
Chronic kidney disease (CKD) is a serious, progressive condition associated with significant
patient morbidity. Hypertension control and use of renin-angiotensin system blockers are …
patient morbidity. Hypertension control and use of renin-angiotensin system blockers are …
[HTML][HTML] Glucagon-like peptide 1 receptor agonist usage in type 2 diabetes in primary care for the UK and beyond: a narrative review
K Fernando, SC Bain, P Holmes, PN Jones, DC Patel - Diabetes Therapy, 2021 - Springer
The scientific landscape of treatments for type 2 diabetes (T2D) has changed rapidly in the
last decade with newer treatments becoming available. However, a large proportion of …
last decade with newer treatments becoming available. However, a large proportion of …
[HTML][HTML] Defining the role of SGLT2 inhibitors in primary care: time to think differently
Disease burden in people with diabetes is mainly driven by long-term complications such as
cardiovascular disease, heart failure and chronic kidney disease. This is a consequence of …
cardiovascular disease, heart failure and chronic kidney disease. This is a consequence of …